Metabolism of 4- (3- (dimethylamino) propyl) -3,4-dihydro-2- (1-hydroxyethyl) -3-phenyl-2H-1,4-benzothiazine (SQ 11,579) under in vitro and in vivo conditions by rats, dogs, and monkey
Lan, S.J.; Chando, T.J.; Cohen, A.I.; Weliky, I.; Schreiber, E.C.
Drug Metabolism and Disposition the Biological Fate of Chemicals 1(4): 619-627
1973
ISSN/ISBN: 0090-9556 PMID: 4149635 Document Number: 68520
Document emailed within 1 workday
Related Documents
Kitamura, S.; Okamoto, Y.; Takeshita, M.; Ohta, S. 1999: Reductive metabolism In vivo of trans-4-phenyl-3-buten-2-one in rats and dogs Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(7): 767-769Küttel, S.; Rácz, I.; Korbonits, D. 1982: In vitro resorption study of a new anti-arrhythmia compound, N-(3,3-diphenyl-propyl)-N'-(1-phenyl-2-propyl)1,3-propylene diamine dihydrochloride Acta Pharmaceutica Hungarica 52(2): 81-90
Pfeifer, S.; Bornschein, I.; Gehrke, A. 1977: Biotransformation of 2-phenyl-4-/beta-dimethylamino-ethyl/-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17 O48) a potential antirheumatic agent Die Pharmazie 32(10): 587-592
Mayr, C.A.; Sami, S.M.; Remers, W.A.; Dorr, R.T. 1998: Identification and characterization of in vitro metabolites of 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz [de,h]isoquinoline-1,3-dione (Azonafide) Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(2): 105-109
Bruno, O.; Ranise, A.; Bondavalli, F.; Schenone, P.; D'Amico, M.; Filippelli, A.; Filippelli, W.; Rossi, F. 1993: 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities Farmaco 48(7): 949-966
Hewitt, N.J.; Bühring, K.U.; Dasenbrock, J.; Haunschild, J.; Ladstetter, B.; Utesch, D. 2001: Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(7): 1042-1050
Coudert, P.; Rubat, C.; Couquelet, J.; Tronche, P. 1990: Synthesis of 6-[(4-imidazol-1-yl)-phenyl]-4-phenyl 4,5-dihydro-2H-pyridazin-3-one: a potential blood platelet aggregation inhibitor Journal de Pharmacie de Belgique 45(3): 191-195
Starek, A. 1992: Circadian variations of phenacetin metabolism in rats in vivo and in vitro Polish Journal of Pharmacology and Pharmacy 44(6): 663-670
Kuperman, A.V.; Kalgutkar, A.S.; Marfat, A.; Chambers, R.J.; Liston, T.E. 2001: Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(11): 1403-1409
Gallenkamp, H.; Wilhelm, T.; Zilly, W.; Richter, E. 1976: Metabolism in vitro and metabolic clearance in vivo of tolbutamide in rats with experimental cholestasis Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 297-300
Wheeler, L.; Strother, A. 1971: In vitro metabolism of the N-methylcarbamates, Zectran and Mesurol, by liver, kidney and blood of dogs and rats Journal of Pharmacology and Experimental Therapeutics 178(2): 371-382
Vlcek, P.; Kovalcík, V. 1979: Effect of reserpine and ascorbic acid on calcium content of aortal tissue of rats under in vivo and in vitro conditions Bratislavske Lekarske Listy 72(2): 223-227
Ishimori, T.; Gotanda, K.; Sasaki, T.; Shinbo, A.; Asano, H.; Miyazawa, K.; Miyasaka, K. 1994: Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs Arzneimittel-Forschung 44(5): 583-588
Tanaka, A.; Watanabe, M. 1982: Distribution and metabolism of 1-propyl-1-nitrosourea in rats Cancer Research 42(9): 3837-3842
Herzig, J.W.; Chiesi, M.; Depersin, H.; Grüninger, S.; Hasenfuss, G.; Kubalek, R.; Leutert, T.; Pieske, B.; Pioch, K.; Wenk, P.; Holubarsch, C. 1996: Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-meth yl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips Arzneimittel-Forschung 46(6): 586-593
Banerjee, B.N.; Sofia, R.D.; Ivins, N.J.; Ludwig, B.J. 1977: Toxicological investigation of 2,3-dihydro-9H-isoxazolo[3,2-b]quinazolin-9-one (W-2429). Acute and subacute toxicity in mice, rats and dogs Arzneimittel-Forschung 27(4): 793-801
Gülerman, N.; Rollas, S.; Ulgen, M. 1998: Synthesis and in vitro microsomal metabolism of 4-ethyl-5-(4-fluorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione and its potential metabolites Bollettino Chimico Farmaceutico 137(5): 140-143
Terazawa, K.; Watanabe, K.; Terabayashi, M.; Kuramoto, S.; Yokomoto, Y.; Otani, K.; Shimamura, K.; Yamashita, K. 1992: Acute toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl) amino] benzoate dimethanesulfonate (FUT-187) in mice, rats and dogs Journal of Toxicological Sciences 17 Suppl 4(6): 1-15
Sinzinger, H.; Rogatti, W. 1994: Prostaglandins and arterial wall lipid metabolism--in vitro, ex-vivo and in-vivo radioisotopic studies Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 45(1): 27-40
Fandeur, T.; Dubois, P.; Gysin, J.; Dedet, J.P.; da Silva, L.P. 1984: In vitro and in vivo studies on protective and inhibitory antibodies against Plasmodium falciparum in the Saimiri monkey Journal of Immunology 132(1): 432-437